Travoprost intracameral implant significantly reduces intraocular pressure and medication use in patients with glaucoma over three years.
Steven R. Sarkisian, Jr., MD
Advertisement
Steven R. Sarkisian, Jr., MD, is the founder and chief executive officer of Oklahoma Eye Surgeons.
Articles by Steven R. Sarkisian, Jr., MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
TRIUMPH-1: Retatrutide Substantially Lowers Weight, BMI in Patients With Obesity or Overweight
2
TRANSCEND-T2D-1: Retatrutide Demonstrates Superior Weight Loss and A1c Results Versus Placebo
3
High-Dose Semaglutide Preserves Kidney Function, Reduces Inflammation in Obesity Without Diabetes
4
Berobenatide Monthly Dosing Shows Weight Loss Efficacy in VESPER Trials, With John Buse, MD, PhD
5